Skip to content
HowShorted

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. short interest in 2021

In 2021, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s disclosed short interest ran from 7.30% of shares outstanding on 15 Jan 2021 to 9.03% on 31 Dec 2021, a change of +1.73 percentage points. The year's high was 9.17% on 15 Dec 2021 and its low 4.61% on 26 Feb 2021, averaging 6.93% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.64 days on 29 Oct 2021. Full history: PACIFIC BIOSCIENCES OF CALIFORNIA, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. in 2021

2021 in figures

Start of year
7.30% (15 Jan 2021)
End of year
9.03% (31 Dec 2021)
Change
+1.73 pp
High
9.17% (15 Dec 2021)
Low
4.61% (26 Feb 2021)
Average
6.93%
Highest days to cover
10.64 (29 Oct 2021)
SEC filings marked
10

Every report in 2021

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20217.30%2.28results (8-K)
29 Jan 20217.21%3.03
12 Feb 20215.03%2.25results (8-K)
26 Feb 20214.61%1.7910-K filed
15 Mar 20215.94%2.27
31 Mar 20216.67%4.13
15 Apr 20216.08%4.46
30 Apr 20216.86%6.00results (8-K)
14 May 20217.07%4.1010-Q filed
28 May 20216.88%6.76
15 Jun 20216.94%7.85
30 Jun 20216.88%5.52
15 Jul 20216.16%7.57
30 Jul 20216.00%4.90results (8-K)
13 Aug 20215.86%5.27results (8-K), 10-Q filed
31 Aug 20216.38%7.17
15 Sep 20216.53%9.51
30 Sep 20217.13%8.39
15 Oct 20217.80%7.52
29 Oct 20218.91%10.64
15 Nov 20218.11%8.46results (8-K), 10-Q filed
30 Nov 20217.69%6.71
15 Dec 20219.17%7.26
31 Dec 20219.03%8.15

See also: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.